Illustration for: Enterprise AI Raised Another $590M You Missed

Enterprise AI Raised Another $590M You Missed

Simile, CAIS, Eliyan and Freehand raised a combined $590M in the last two weeks of July for synthetic-user modeling, alternative-investment AI, chip interconnects and supply-chain agents โ€” infrastructure and tooling money the model-layer headlines mostly missed.

By the Numbers

~$590M, 4 deals
Combined
$200M ($2B val.)
Simile
$170M ($2B+ val.)
CAIS
$145M ($1B val.)
Eliyan
$75M Series B
Freehand
TC
By the Funding Desk
Edited by Trace Cohen ยท Early-stage VC & angel ยท Founder, New York Venture Partners
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

None of the four builds a model: simulating focus groups, powering wealth-advisor research, moving data between chips and automating procurement are the unglamorous layers, and they absorbed roughly $590 million in the final days of July.

2

Simile's $200 million at a $2 billion valuation came five months after its $100 million Series A, a step-up pace that prices the agentic-twins thesis well ahead of any disclosed market-research revenue.

3

Eliyan is the outlier risk of the four -- forecasting hundreds of millions in 2027 sales off low millions in 2025 assumes chiplet shipments scale on schedule, and Cisco's backing does not de-risk a hardware timeline.

4

Freehand's supply-chain agents already run spend for Meta, Unilever and Pfizer and CAIS's research assistant runs on Anthropic's Claude, so two of the four are selling into committed enterprise budgets rather than experimental ones.

TC

The VC Read ยท Trace's Take

Trace Cohen

Eliyan is the one I'd diligence hardest of the four โ€” a jump from low-millions 2025 revenue to a forecasted hundreds-of-millions by 2027 assumes chiplet shipments hit schedule with zero slippage, and physical-hardware startups have a worse track record hitting shipment timelines than software ones. The other three (Simile, CAIS, Freehand) all have real, disclosed revenue multiples backing their marks, which is the more interesting story than the round sizes.

Analysis

Four AI-adjacent companies raised a combined roughly $590 million in the final days of July, none of it a foundation-model round. Simile, which builds AI-simulated "agentic twins" of human behavior for market research, raised $200 million in a Series B at a $2 billion valuation led by Greenoaks, five months after a $100 million Series A, TechCrunch reported. CAIS, the alternative-investments platform for wealth managers whose research assistant runs on Anthropic's Claude, raised $170 million led by Vista Equity Partners at a valuation above $2 billion, according to citybiz. Eliyan, a Cisco-backed chiplet-interconnect startup building electro-optical links to fix AI chip data bottlenecks, raised $145 million at a $1 billion valuation, per SiliconANGLE. And Freehand, whose AI agents manage supply-chain spend for Meta, Unilever and Pfizer, raised a $75 million Series B, Crunchbase News reported.

What connects the four is where they sit in the stack: none builds a model, and each solves a narrow, unglamorous problem โ€” simulating focus groups, powering wealth-advisor research, moving data between chips faster, and automating back-office procurement. That's the same app-and-infrastructure-layer pattern Pulse tracked in an earlier week, just with a different four companies and a different two weeks.

The risk in treating four unrelated rounds as one trend is real โ€” correlation across a two-week window doesn't prove the app layer is outpacing the model layer, only that late July had a cluster of strong raises. Eliyan in particular is worth watching closely: it's forecasting "hundreds of millions" in 2027 sales off "low millions" in 2025 revenue, a jump that assumes chiplet shipments scale on schedule this year.

ShareXLinkedInEmail

Key Sources

2 sources

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.